Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx) Recall
Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)
FDA recall Class II
Ongoing
FDA lists this Class II recall for Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx). Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1927-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Mar 20, 2026
- FDA report date
- Apr 29, 2026
- Quantity in commerce
- 163 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)
Affected model & UDI checker
Search the exact identifiers published for Z-1927-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| SEQ0067 | Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx) | Check source notice | Not specified |
FDA code information
Model Number: SEQ0067. Lot Numbers: 24346, 24386, 24488.
Why was this product recalled?
Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Foundation Medicine, Inc. take?
Foundation Medicine notified consignees via emailed letter on about 03/20/2026. Consignees were instructed to review, complete, sign and return the provided business reply form and review inventory and identify affected units, quarantine those units, and return to the FMI Boston Warehouse quarantine location via standard laboratory transfer practices. Consignees were also instructed to forward the notification to anyone within the facility that should be informed and if there is any impact that requires this notice to be forwarded to another facility, including facilities where units of inventory may have been transferred, contact that facility and provide them with this letter. Consignees were asked to retain the letter with laboratory records made aware that Foundation Medicine will work with the supplier of these components to replace impacted units.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1927-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology